Opportunity
NIH Reporter #11244315
NCI Solicitation for Computational Tools to Track Tumor Evolution in Metastatic Breast Cancer
Buyer
National Cancer Institute (NCI)
Posted
July 06, 2026
Identifier
11244315
NAICS
541715, 541714
This opportunity from the National Cancer Institute (NCI) seeks innovative solutions for tracking tumor evolution in metastatic breast cancer. - Government Buyer: - National Cancer Institute (NCI) - Project Scope: - Development of computational tools to track tumor evolution in metastatic breast cancer - Utilization of molecular techniques, tissue banks, organoid models, and machine learning - Addressing challenges related to large and complex datasets - Collaboration: - Project involves collaboration between the University of Pittsburgh and Carnegie Mellon University - Products/Services Requested: - No specific products, part numbers, or purchase quantities listed - Focus is on research and development services, not commercial off-the-shelf products - Unique Requirements: - Emphasis on improving precision treatment options for late-stage metastatic breast cancer - Integration of advanced computational and biological methods - OEMs and Vendors: - No specific OEMs or vendors mentioned in the solicitation - Estimated Value: - $54,538
Description
This project involves developing computational tools to track tumor evolution in metastatic breast cancer. It utilizes molecular techniques, tissue banks, organoid models, and machine learning methods to address challenges related to dataset size and complexity. The collaboration is between the University of Pittsburgh and Carnegie Mellon University, aiming to improve precision treatment options for late-stage metastatic breast cancer.